DrugDashboards

Paroxetine

Paroxetine · PAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1 · Tablet, Film Coated, Extended Release · Oral · Alembic Pharmaceuticals Limited

NDC 46708-0768-30 · 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for paroxetine (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA217280
TE code
AB
Approval date
Sep 24, 2025
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Paroxetine (Tablet, Film Coated, Extended Release)

LabelerStrengthFirst seenLast seen
Alembic Pharmaceuticals Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCPAROXETINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCPAROXETINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCPAROXETINE HYDROCHLORIDE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCPAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCPAROXETINE HYDROCHLORIDE HEMIHYDRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCPAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCPAROXETINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCPAROXETINE HYDROCHLORIDE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCPAROXETINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Paroxetine — NDC 46708-0768-30," retrieved September 3, 2026, https://drugdashboards.com/drug/46708076830.

Free to cite with attribution — see how the data is put together.